Pharmaceutical
With our biomolecular modelling and data analytics capabilities, we can provide insight into biological pathways, develop proxies for natural materials and design novel drug delivery to help the pharmaceutical and life-sciences sectors.
OUR PARTNERS
CASE STUDIES
Enhancing drug delivery with synthetic virus-like particles
STFC Hartree® Centre worked with IBM and the National Physical Laboratory (NPL) through the Hartree National Centre for Digital Innovation (HNCDI) to accelerate virus-inspired drug delivery research.
Cognitive chemical manufacturing
We worked with AstraZeneca to optimise their chemical manufacturing processes, saving time and costs in large scale product production and manufacturing.
Simulation and machine learning for future medicine
We worked with AstraZeneca to accelerate lead optimisation by providing insights on a new class of drugs with the potential to reduce costs and increase productivity.
Using big data to streamline early stage drug development
We’re part of ADDoPT; an academic-industrial knowledge base collaboration with the UK pharmaceutical industry to accelerate advanced digital design techniques and streamline development.
Designing novel antimicrobial peptides
Ingenza is working with researchers based at the Hartree Centre on molecular simulation techniques with the potential to reduce the time and costs associated with bringing new drug designs to market.
Improving personalised disease diagnostics
By analysing microbiome data, IBM Research scientists based at the STFC Hartree Centre are working to predict whether an individual has an illness, a predisposition to a disease, or how a disease has developed in a non-invasive way.